HRP20000496A2 - Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers - Google Patents

Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers Download PDF

Info

Publication number
HRP20000496A2
HRP20000496A2 HR20000496A HRP20000496A HRP20000496A2 HR P20000496 A2 HRP20000496 A2 HR P20000496A2 HR 20000496 A HR20000496 A HR 20000496A HR P20000496 A HRP20000496 A HR P20000496A HR P20000496 A2 HRP20000496 A2 HR P20000496A2
Authority
HR
Croatia
Prior art keywords
formula
pyridone
hydroxy
use according
residue
Prior art date
Application number
HR20000496A
Other languages
English (en)
Croatian (hr)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HRP20000496A2 publication Critical patent/HRP20000496A2/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HR20000496A 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers HRP20000496A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren

Publications (1)

Publication Number Publication Date
HRP20000496A2 true HRP20000496A2 (en) 2000-12-31

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000496A HRP20000496A2 (en) 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers

Country Status (27)

Country Link
US (1) US6534528B1 (enExample)
EP (1) EP1049468B1 (enExample)
JP (1) JP5127091B2 (enExample)
KR (1) KR100597332B1 (enExample)
CN (1) CN1128619C (enExample)
AR (1) AR016445A1 (enExample)
AT (1) ATE360418T1 (enExample)
AU (1) AU752406B2 (enExample)
BR (1) BR9907734A (enExample)
CA (1) CA2319359C (enExample)
CY (1) CY1106684T1 (enExample)
DE (2) DE19802708A1 (enExample)
DK (1) DK1049468T3 (enExample)
ES (1) ES2285829T3 (enExample)
HR (1) HRP20000496A2 (enExample)
HU (1) HU228824B1 (enExample)
IL (1) IL137453A (enExample)
ME (1) MEP55908A (enExample)
NZ (1) NZ505898A (enExample)
PL (1) PL192550B1 (enExample)
PT (1) PT1049468E (enExample)
RS (1) RS50903B (enExample)
RU (1) RU2212239C2 (enExample)
SI (1) SI1049468T1 (enExample)
SK (1) SK285350B6 (enExample)
TR (1) TR200002118T2 (enExample)
WO (1) WO1999037300A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
ES2525387T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Composiciones que contienen peróxido de hidrógeno o sustancias que ponen en libertad peróxido de hidrógeno
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
RS61907B1 (sr) 2015-04-06 2021-06-30 Subdomain Llc Polipeptidi koji sadrže de novo vezujući domen i njihova primena

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
AR242187A1 (es) * 1986-04-18 1993-03-31 Hoechst Ag Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
PT865278E (pt) * 1995-12-04 2002-10-31 Aventis Pharma Gmbh Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele

Also Published As

Publication number Publication date
DK1049468T3 (da) 2007-07-30
HUP0200851A1 (hu) 2002-07-29
DE19802708A1 (de) 1999-07-29
TR200002118T2 (tr) 2000-12-21
YU43700A (sh) 2003-08-29
PL192550B1 (pl) 2006-11-30
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
AU752406B2 (en) 2002-09-19
CA2319359A1 (en) 1999-07-29
AR016445A1 (es) 2001-07-04
SK285350B6 (sk) 2006-11-03
JP2002501020A (ja) 2002-01-15
US6534528B1 (en) 2003-03-18
EP1049468B1 (de) 2007-04-25
AU2278799A (en) 1999-08-09
ATE360418T1 (de) 2007-05-15
IL137453A (en) 2005-11-20
EP1049468A1 (de) 2000-11-08
HU228824B1 (en) 2013-05-28
NZ505898A (en) 2002-06-28
PL342055A1 (en) 2001-05-21
BR9907734A (pt) 2000-10-17
MEP55908A (en) 2011-05-10
SI1049468T1 (sl) 2007-08-31
PT1049468E (pt) 2007-05-31
CA2319359C (en) 2008-03-18
CY1106684T1 (el) 2012-05-23
KR20010034325A (ko) 2001-04-25
IL137453A0 (en) 2001-07-24
ES2285829T3 (es) 2007-11-16
DE59914312D1 (de) 2007-06-06
SK10892000A3 (sk) 2000-12-11
HUP0200851A3 (en) 2003-05-28
CN1128619C (zh) 2003-11-26
CN1288380A (zh) 2001-03-21
RS50903B (sr) 2010-08-31
KR100597332B1 (ko) 2006-07-10
JP5127091B2 (ja) 2013-01-23
RU2212239C2 (ru) 2003-09-20
HK1034447A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
WO2002087563A3 (en) Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
JP2010077143A (ja) 創傷治療用外用剤
TR200101903T2 (tr) Yeni malonik asit türevleri, bunların preparasyon işlemleri.
JP2018525348A (ja) 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用
CZ254197A3 (cs) Multifunkční enzym
GB2048070A (en) Medication for Open Wounds
JP6169693B2 (ja) 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤
HRP20000496A2 (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
RU2191574C2 (ru) Лекарственное средство, обладающее регенерирующим и ранозаживляющим действием
EP2570124A1 (en) Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
CZ295316B6 (cs) Léčivo k léčbě bércových vředů a proleženin
MXPA00007000A (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
RS55672B1 (sr) Supstance oleuropeina za lečenje rana i čireva kod starijih ljudi i/ili dijabetičara
HK1034447B (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
RU2122401C1 (ru) Ранозаживляющая композиция
JPH04208219A (ja) 褥瘡及び皮膚潰瘍治療外用剤
JP2007277135A (ja) 創傷治療用外用剤
WO2007084127A1 (en) Use of gluten for wound treatment as active healing ingredient
Steenvoorde et al. An unexpected effect of Dermacyn on infected leg ulcers
JPWO1996033733A1 (ja) 新規な皮膚欠損症治療剤
HK1065719B (en) Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20081231

Year of fee payment: 11

ODBI Application refused